产品中心 流式试剂&相关 流式抗体

所有图片(1/1)

Mouse Anti-Human B7-H4 Antibody (S-3024)

V-set domain-containing T-cell activation inhibitor 1,B7 homolog 4 (B7-H4),B7h.5,Immune costimulatory protein B7-H4,Protein B7S1,T-cell costimulatory molecule B7x,B7H4,VTCN1

价格 600.00 1-2周
货号 S0B8368
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    B7-H4
  • 分子别名

    V-set domain-containing T-cell activation inhibitor 1; B7 homolog 4 (B7-H4); B7h.5; Immune costimulatory protein B7-H4; Protein B7S1; T-cell costimulatory molecule B7x; B7H4; VTCN1
  • 细胞定位

    Cell membrane
  • Accession

    Q7Z7D3
  • 克隆号

    S-3024
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1,k
  • 反应种属 ?

    Hu
  • 阳性样本

    SK-BR-3
  • 纯化方式

    Protein G
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度 推荐种属
    FCM 1:2000 Hu
背景介绍
  • B7-H4, also known as VTCN1 or B7x, is a ~50 kDa type-I trans-membrane glycoprotein of the B7 immunoglobulin superfamily that consists of an extracellular IgV-IgC domain pair, a single trans-membrane segment and a short cytoplasmic tail; it is expressed inducibly on antigen-presenting cells and constitutively on many epithelial cancers, where it acts as an immune-checkpoint ligand by binding an as-yet-unidentified receptor on activated CD4⁺ and CD8⁺ T cells, thereby arresting the cell cycle in G0/G1, suppressing IL-2 production and proliferation, and enabling tumours to evade immunity, making it an emerging target for cancer immunotherapy.

  • 流式分析

    • Flow cytometric analysis of SK-BR-3 (Human breast adenocarcinoma epithelial cell, Left) / HeLa (Human cervix adenocarcinoma epithelial cell, Right) labelling B7-H2 antibody at 1/2000 dilution (0.1 μg) / (Red) compared with a Mouse IgG1, κ (Black) Isotype Control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Mouse IgG Alexa Fluor® 647 was used as the secondary antibody.
      Negative control: HeLa

评论(0)